the market in addition to the training of new users enabled this technique to take off throughout the world.
Detachable balloons are still used today in the treatment of fistulas and the occlusion of vessels.
2) At the end of the eighties, the micro coil emerged as an excellent device for embolization. In 1991, Dr Guido Guglielmi, an italian doctor who was then a researcher in Los Angeles, invented the GDC (Guglielmi Detachable Coil), an electrical system which allows the practitioner to control the moment when At a time when endothelial prostheses or "flow diverters" appear to be on the point of revolutionising the treatment of intracerebral aneurysms, we thought it would be interesting to write a short article tracing the history of endovascular techniques for treating this pathology as well as the evolution of the instruments available.
We have no intention of going into a medical discussion; we will simply provide an overview of an industrial experience. the embolization coil is detached. The GDC is by far the best known system and it is still manufactured by the American firm, Boston Scientific.
I. History
3) In 1993, Leopold Plowiecki and Professor Jacques Moret developed the MDS (Mechanical Detachment System for coils) which was, and is still manufactured in France by BALT Extrusion. Following this, several other types of coil detachment systems emerged (the hydraulic system by Microvention and Cordis and the electrical system by Micrus) which made this technique the accepted standard for the embolization of intracerebral aneurysms. 4) In 1996, when the aneurysms treated with coils were getting more and more complex, Professor Moret developed a technique using flexible balloons to maintain coils during their compaction inside the aneurismal sac, avoiding any protrusion into the parent artery and thus enabling the treatment of wide-neck aneurysms. The first "remodelling" balloons, the Moret catheters, were manufactured by Balt Extrusion.
They were made of latex and attached to double lumen micro Magic catheters.
At the end of the nineties, the American firm MIS (later taken over by EV3) developed a catheter called Grapevine which had a balloon made of a flexible elastomer.
For their part, Balt Extrusion launched a new single-lumen catheter with an elastomer balloon called the Magellan, followed by the Copernic and to complete the list, Eclipse was launched in 2005.
5) The necessity to maintain the coils in place permanently in order to treat increasingly complex aneurysms became more and more evident. As the first attempts to use coronary stents in the brain were taking place in 2001, Leopold Plowiecki created the first intracerebral stent.
This stent was cut out of a tube made of platinum and iridium and crimped onto a balloon. It was called the BOA Platinum and later became Channel.
6) In spite of the progress in "balloon expandable" stents, their rigidity remained a handicap in many cases. It was in this context that, in 2001, SMART Therapeutics, which was MDS -Mechanical Detachment System.
The MORET CATHETER with double lumen and latex balloon. rapidly taken over by Boston Scientific, developed the first self-expandable intracerebral stent made of Nitinol, the Neuroform.
This type of stent, very flexible and not requiring the use of a rigid balloon, henceforth enabled most intracerebral aneurysms to be treated with stents.
7)
In 2003, Balt Extrusion developed a new type of intracranial self-expandable stent: the LEO (evoking the name of Leopold Plowiecki). Its specificity is that it is braided with a Nitinol wire which provides it with an excellent memory for shapes and allows it to adapt to very tight bends in the arteries of the brain without becoming bulbous.
Two months later, on the 10 th of October 2003.
A fusiform aneurysm just after implantation with the three LEO stents.
Dr Carlo Venturi and Prof. Alfredo Casasco after the world's first use of stents for the treatment of a fusiform aneurysm. On 31 July 2003 In Sienna, three LEO stents (5.5 x 35 mm) were used one inside another within the basilar artery.
LEO, the Self-expandable braided stent.
8) The widespread use of self-expandable stents was accompanied by the emergence of problems linked to the thrombogenicity of these new prostheses which highlighted the primordial importance of parameters such as the medicated preparation (and the eventual resistance of the patient to this) as well as the capacity of the stents to open correctly and to adapt to the anatomy of the arteries easily. At the same time, the beneficial effect of stenting on the reduction seen in the number of recanalisations is confirming itself and justifies the continuation of research in this field which has led to the development of new generations of endoprostheses: Neuroform-3 (Boston Scientific and Enterprise (Cordis). These stents, which are still based on the technology of cutting out from a Nitinol tube, are quite rigid laterally due to the fact that the wires are welded together.
9) The LEO+, developed in 2006 by Nicolas Plowiecki, is a braided stent like the LEO, but with a greater radial strength and a denser mesh.
The Enterprise stent (Cordis)
The LEO+ stent
The self-expandable braided endothelial prosthesis, SILK
II. The Development of the endothelial prosthesis, SILK
The SILK is the result of research into the miniaturisation of the first braided stent, LEO. Whereas this first stent, with its positioning system, was developed by Leopold Plowiecki, the research on the SILK was directed by his son, Nicolas Plowiecki.
The Research and Development on the SILK lasted four years, both for the engineering and design department and in the prototype workshop as well as for the in-vitro and animal trials. Thanks to this patience and of course, thanks to the precious opinions of medical advisors, Nicolas Plowiecki managed to build a prosthesis which was braided very densely with different diameters of wire, as well as a simple and reliable opening system. The wires, which are either made of Nitinol or platinum, are thinner than a hair (for information, the diameter of a hair varies from 30 to 120 microns). These thin, braided wires give SILK its appearance of a silk stocking, hence its name.
Numerous tests on animals (rabbits and sheep) were carried out according to applicable standards for products which can be implanted into the human body. Histological studies of these implants have proven that the SILK is perfectly well tolerated thanks to its excellent Histological cross-section of a sheep's artery where a SILK has been implanted SILK, can replace coils. This endothelial prosthesis is so flexible that great risks are involved in placing it. It is fundamental to have extensive training before use: 1. Medicated preparation for the patient 2. Determination of the dimensions of the prosthesis (diameter as well as length) 3. Opening technique training 4. Post-operative follow-up
We wanted to finish this article by insisting on the precautions that are so important to respect when using this new device. flexibility and the fact that it is very rapidly covered with endothelium which forms naturally on the dense braiding. It is for this reason that one can call this stent, as Professor Luc Picard does, an "endothelial prosthesis". As is often the case, good ideas emerge at the same time in different places in the world: as the SILK appeared in France, a Californian start-up company, Chestnut Medical, was working on a similar prosthesis called the Pipeline. Chestnut was acquired by EV3 in June 2009.
Examples of clinical cases carried out using the SILK
Numerous studies are still necessary to determine whether the endothelial prosthesis,
